Initial Statement of Beneficial Ownership (3)
2020年11月10日 - 8:46AM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Lee Catherine Chai-zon |
2. Date of Event Requiring Statement (MM/DD/YYYY)
11/5/2020
|
3. Issuer Name and Ticker or Trading Symbol
Metacrine, Inc. [MTCR]
|
(Last)
(First)
(Middle)
C/O METACRINE, INC., 3985 SORRENTO VALLEY BLVD.,SUITE C |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner ___X___ Officer (give title below) _____ Other (specify below) EVP, Gen. Counsel & Secretary / |
(Street)
SAN DIEGO, CA 92121
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Employee Stock Option (Right to Buy) | (1) | 8/20/2030 | Common Stock | 137253 | $10.51 | D | |
Explanation of Responses: |
(1) | 25% of the shares subject to the stock option shall vest one year after the Vesting Commencement Date of August 21, 2020, and the remaining shares shall vest in 36 equal monthly installments thereafter. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Lee Catherine Chai-zon C/O METACRINE, INC. 3985 SORRENTO VALLEY BLVD.,SUITE C SAN DIEGO, CA 92121 |
|
| EVP, Gen. Counsel & Secretary |
|
Signatures
|
/s/ Catherine C. Lee | | 11/9/2020 |
**Signature of Reporting Person | Date |
Metacrine (NASDAQ:MTCR)
過去 株価チャート
から 6 2024 まで 7 2024
Metacrine (NASDAQ:MTCR)
過去 株価チャート
から 7 2023 まで 7 2024
Real-Time news about Metacrine Inc (ナスダック市場): 0 recent articles
その他のMetacrine, Inc.ニュース記事